Social Media Press Releases

RSS

Showing Press Releases with Tag: monoclonal antibody

5/08/2007

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease

» read more
4/30/2007

MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE® Molecule

» read more
4/23/2007

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion

» read more
4/18/2007

Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA

» read more
3/23/2007

MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis

» read more
2/20/2007

MedImmune Further Expands its Commercial Organization Expertise With Appointment of Two Additional Vice Presidents

» read more
2/07/2007

MedImmune Reports Financial Results For 2006

» read more
12/28/2006

MedImmune In-Licenses Novel Inflammatory Disease Target

» read more
12/19/2006

MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa

» read more
12/09/2006

MedImmune’s Advancing Cancer Pipeline to Be Highlighted at the American Society of Hematology’s Annual Meeting

» read more
11/06/2006

Numax® Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis®

» read more
10/26/2006

MedImmune Reports Financial Results for 2006 Third Quarter and Nine-Month Period

» read more
9/29/2006

MedImmune Named One of Maryland’s Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

» read more
9/13/2006

MedImmune Breaks Ground on New Biologics Manufacturing Facility in Frederick, Maryland

» read more
8/21/2006

MedImmune Files Investigational New Drug Application for MT103

» read more